Successful treatment and complete recovery depend on accurate and rapid diagnosis. Today, most in-vitro diagnostics (IVD) are performed in hospital central laboratories or large testing facilities to reduce costs. However, healthcare is facing challenges such as workforce shortages, complex procedures, long testing turnaround times, and limited resources. As a result, the development of patient-centered point-of-care testing (POCT) medical devices has become a future trend. POCT enables testing in hospitals, clinics, examination rooms, ambulances, field settings, or even at home. BioTMC is dedicated to developing diagnostic and testing tools that improve people’s lives. We provide an innovative multiplex molecular testing platform that enables faster and smarter medical decision-making, ultimately transforming human health management. AcesoBox, as a next-generation ultra-rapid molecular diagnostic system, can complete nucleic acid testing within 10-15 minutes, providing critical rapid diagnostic capabilities for emergency rooms, ambulances, and other urgent care settings.